Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Effectiveness of Lymphatic Bypass Supermicrosurgery for Primary Lymphedema Prevention After Breast Cancer Axillary Lymph Node Dissection: a Randomized Controlled Study

NCT05682885 is registered in ClinicalTrials.gov with Dharmais National Cancer Center Hospital as lead sponsor.

NCT NCT05682885
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05682885 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Effectiveness of Lymphatic Bypass Supermicrosurgery for Primary Lymphedema Prevention After Breast Cancer Axillary Lymph Node Dissection: a Randomized Controlled Study
Lead sponsor
Dharmais National Cancer Center Hospital
Phase
Not applicable
Overall status
Active, not recruiting
Start date
October 6, 2022
Completion date
November 18, 2027
Enrollment
140 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer related lymphedema, lymphedema arm